Caribou Biosciences, Inc. (CRBU)
0.2931
-0.02
(-5.60%)
USD |
NASDAQ |
Nov 20, 10:36
Caribou Biosciences Free Cash Flow : -92.99M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -92.99M |
| June 30, 2026 | -95.75M |
| March 31, 2026 | -101.64M |
| December 31, 2025 | -112.35M |
| September 30, 2025 | -127.73M |
| June 30, 2025 | -135.76M |
| March 31, 2025 | -142.20M |
| December 31, 2024 | -143.08M |
| September 30, 2024 | -130.75M |
| June 30, 2024 | -130.95M |
| March 31, 2024 | -113.58M |
| December 31, 2023 | -104.90M |
| Date | Value |
|---|---|
| September 30, 2023 | -108.05M |
| June 30, 2023 | -98.24M |
| March 31, 2023 | -104.99M |
| December 31, 2022 | -97.42M |
| September 30, 2022 | -92.69M |
| June 30, 2022 | -84.86M |
| March 31, 2022 | -77.33M |
| December 31, 2021 | -34.64M |
| September 30, 2021 | -20.67M |
| June 30, 2021 | -13.48M |
| March 31, 2021 | -3.775M |
| December 31, 2020 | -33.53M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Anavex Life Sciences Corp. | -29.29M |
| Vaxcyte, Inc. | -994.76M |
| Foghorn Therapeutics, Inc. | -83.68M |
| Bolt Biotherapeutics, Inc. | -24.80M |
| Connect Biopharma Holdings Ltd. | -56.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.52M |
| Cash from Investing (Quarterly) | 19.39M |
| Cash from Financing (Quarterly) | 2.989M |
| Free Cash Flow Per Share (Quarterly) | -0.2096 |
| Free Cash Flow to Equity (Quarterly) | -22.22M |
| Free Cash Flow to Firm (Quarterly) | -22.54M |
| Free Cash Flow Yield | -293.7% |